|Bid||43.02 x 2900|
|Ask||43.13 x 900|
|Day's Range||39.13 - 47.17|
|52 Week Range||8.51 - 129.71|
|Beta (5Y Monthly)||2.93|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||88.08|
Shares of Arcturus Therapeutics (NASDAQ:ARCT) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 64.47% over the past year to ($1.25), which missed the estimate of ($0.88). Revenue of $2,238,000 declined by 24.60% year over year, which missed the estimate of $2,360,000. Looking Ahead Earnings guidance hasn't been issued by the company for now. Arcturus Therapeutics hasn't issued any revenue guidance for the time being. Conference Call Details Date: Mar 01, 2021 View more earnings on ARCT Time: 04:30 PM ET Webcast URL: http://public.viavid.com/player/index.php?id=143486 Price Action 52-week high: $129.71 Company's 52-week low was at $8.51 Price action over last quarter: Up 37.13% Company Description Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-2020. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For March 1, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 1, 2021 at 4:30 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.